SynektikS.A.

Agents specialised in the sale of other particular products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-02-04
Activity description

Synektik offers complementary products and services for medical facilities. The Group delivers multidisciplinary projects tailored to the needs of these facilities.

Registered address
ul. Józefa Piusa Dziekońskiego 3, 00-728 Warszawa, Poland
Website
synektik.plWebsite active
Phone
Social media
Electronic delivery address
AE:PL-63755-35647-AUWBR-26

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Stock quotes

PLN 341.60
-5.20 (-1.50%)
340.00345.00350.00341.6010:0012:0014:0016:00
Open
PLN 346.00
High
PLN 349.80
Low
PLN 338.20
Volume
25.58K
Avg. vol.
24.21K
Market cap
PLN 2.91B
P/E ratio
6.98
EPS
PLN 48.93
Shares outstanding
8.53M
52-week
PLN 338.20 – 359.20
Dividend yield
3.15%
Dividend
PLN 10.75
Ex dividend date
Jan 28, 2026
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 78.95mUSD 17.86mUSD 14.88m
Q1 2026USD 57.59mUSD 14.51mUSD 80.05m
Q4 2025USD 57.25mUSD 13.55mUSD 8.78m
Q3 2025USD 50.03mUSD 12.44mUSD 7.77m

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 20.03mMedianUSD 223.73kAverageUSD 2.35m
Net profit
This companyUSD 23.09mMedianUSD 5.75kAverageUSD 144.55k
Operating costs
This companyUSD 15.94mMedianUSD 186.16kAverageUSD 2.11m
Assets
This companyUSD 86.82mMedianUSD 166.04kAverageUSD 1.41m

Bank accounts

Registered as a VAT taxpayer on 2003-12-31. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Jul 29, 2011Commercial Companies Code notice
Jul 11, 2011Commercial Companies Code notice
Mar 7, 2011Transformation registered

Public aid

14 public aid cases recorded, with a total value of $1,327,049.

Grant datePurposeGross amountGranting body
Dec 18, 2025
De minimis aid (in accordance with Commission Regulation 2023/2831)
$65,153Prezes Banku Gospodarstwa Krajowego
Oct 27, 2023
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$145,740Prezes Banku Gospodarstwa Krajowego
Aug 5, 2021
Other crisis aid
$53,718Prezes Banku Gospodarstwa Krajowego

European Funds

5 projects recorded: 4 from FE lists ($2,414,370) and 1 Commission grant (FTS) ($4,079,437).

StartProjectEU co-financingProgramme
2020-01-02
Jezioro danych w radiologii - opracowanie repozytoriów do celów badawczych
$246,440Regionalny Program Operacyjny Województwa Mazowieckiego na lata 2014-2020
2019-09-01
Dozymetria a diagnostyka obrazowa - skuteczna ochrona radiologiczna pacjentów
$193,247Regionalny Program Operacyjny Województwa Mazowieckiego na lata 2014-2020
2017-07-01
Platforma Evolution odpowiedzią na proces eksperymentowania i poszukiwania nisz rozwojowych i innowacyjnych na styku wybranych inteligentnych specjalizacji
$505,110Regionalny Program Operacyjny Województwa Mazowieckiego na lata 2014-2020

Tenders

363 tenders recorded as contractor: 129 national ($10,166,603) and 234 EU ($5,957,872,849).

Publication dateSubjectAmountContracting authority
Sep 25, 2026
Dzierżawa robota chirurgicznego z wyposażeniem oraz narzędziami do przeprowadzenia zabiegów chirurgicznych.
—Szpital Ogólny w Wysokiem Mazowieckiem
Sep 23, 2026
Dostawa zestawu chirurgii robotycznej z świadczeniem usługi napraw, konserwacji z dedykowanymi narzędziami oraz materiałami zużywalnymi - dzierżawa systemu.
—Specjalistyczny Szpital Im. Dra Alfreda Sokołowskiego
Sep 18, 2026
Wykonanie pogwarancyjnej obsługi serwisowej aparatury medycznej dla Świętokrzyskiego Centrum Onkologii w Kielcach.
—Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach

Regulatory authorisations

AuthorityTypeStatus
BDO
BDO register entry Active

Authorized Representatives

Artur Mieczysław Ostrowski — Attorney-in-fact (joint)
Cezary Dariusz Kozanecki — President of the Management Board
Dariusz Marcin Korecki — Vice President of the Management Board
Tomasz Wróbel — Management Board Member

Manner of representation

If the management board is a multi-member management board, the President of the Management Board independently, or two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy, are authorized to submit declarations of will on behalf of the company.

Supervisory board

Andrzej Piotr Jacaszek — Supervisory Board Member
Michał Daniel Dobak — Supervisory Board Member
Mariusz Wojciech Książek — Supervisory Board Member
Wiesław Tadeusz Łatała — Supervisory Board Member
Sawa Zuzanna Zarębińska — Supervisory Board Member

Beneficial owners

No beneficial owners recorded for the company Synektik.

Subsidiaries

NameShare valueStake
It4kansp. z o.o.
1,620.75 USD100%
LOM Scansp. z o.o.
26,931.39 USD48.9926%
Synektik Pharmasp. z o.o.
2,714.75 USD100%

Competitors

NameRevenueWebsite
Olympus Polskasp. z o.o.$77,594,927.17olympus.pl
SkamexS.A.$75,913,376.60skamex.com.pl
ComsetS.A.$23,191,634.46comset.pl
Synkmedsp. z o.o.$20,634,200.47synkmed.pl
Biochem PolskaS.A.$13,180,007.81biochempolska.pl
Medif sp. z o.o.sp. k.$13,126,958.83medif.com
PromedS.A.$12,643,674.56promed.com.pl
MassmedicaS.A.$8,216,274.00massmedica.com
Medcomplexsp. z o.o.$5,193,830.09medcomplex.pl
Inobesp. z o.o.$3,086,358.88inobe.pl

Change history

DateEvent
2021-08-13Address change (Al. Witosa 31, 00-710, Warszawa → Ul. Józefa Piusa Dziekońskiego 3, 00-728, Warszawa)
2015-01-19PKD change (Removed: 21.20.Z, 26.60.Z, 33.12.Z, 33.14.Z, 33.20.Z, 46.19.Z, 46.6, 47.19.Z, 47.73.Z, 47.74.Z, 47.79.Z, 47.9, 58.2, 64.20.Z, 69.20.Z, 70.10.Z, 70.22.Z, 71.12.Z, 73.1, 73.20.Z, 77.33.Z, 77.39.Z, 82.30.Z, 82.99.Z, 85.59.B, 86.90.D, 93.19.Z, 96.09.Z)
2014-07-15Address change (Rakowiecka 36, 02-532, Warszawa → Al. Witosa 31, 00-710, Warszawa)
2014-01-03Share capital change (3,359,564.50 PLN → 4,264,564.50 PLN)
2013-08-28Share capital change (3,341,000.00 PLN → 3,359,564.50 PLN)

FAQ

Last updated: 2026-03-27